海南惠普森医药生物技术有限公司 China Pharma Holdings Inc.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
China Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025 2024-08-19 20:00
China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split 2024-02-24 05:05
China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device 2023-11-29 21:00
China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs 2023-08-09 20:30
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split 2023-02-25 05:05
China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask 2022-12-28 21:00
China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19 2022-12-15 21:00
China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project 2022-12-05 21:00
China Pharma Announces Receipt of Noncompliance Notice from NYSE American 2022-12-03 05:10
China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency 2022-10-02 10:05
China Pharma Announced the Submission of a Plan of Compliance to NYSE American 2022-07-18 20:00
China Pharma Announces Receipt of Noncompliance Notice from NYSE American 2022-06-23 05:00
China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results 2022-03-31 20:00
China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results 2021-11-13 05:30
China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results 2021-08-14 04:30
China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval 2021-08-05 21:00
China Pharma to Launch Highly Purified NMN+PQQ Product 2021-06-09 20:00
China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue 2021-05-15 04:30
China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port 2021-04-19 20:30
China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results 2021-03-27 05:00
1 2 3 4 5 9